Advertisement

Public Health

Delivering multiple vaccines in both arms, rather than just one, substantially increases antibody responses, new research suggests. 

As key indicators of COVID-19 and respiratory syncytial virus continue to fall, the number of states reporting high levels of virus activity is also decreasing. 

In 2022, 22 states and the District of Columbia reported clinical cases of Candida auris, a fungus deemed an urgent public health threat due to its resistance to multiple antifungal treatments. 

Advertisement

While COVID-19 and respiratory syncytial virus metrics continue to decrease, flu activity remains high and is rising again in some parts of the country, especially in the Midwest and South-Central regions.

The beta variant was the most deadly of all the COVID-19 strains that the World Health Organization deemed variants of concern, according to a meta-analysis published Jan. 31. 

Early trials for a vaccine to prevent dengue infections, responsible for more than 5 million cases and 5,000 deaths in 2023, are underway and showing success, according to data published Feb. 1 in The New England Journal of Medicine.

Advertisement